Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications

International Journal of Radiation Oncology Biology Physics

Volumn 48, Issue 5, 2000, Pages 1311-1322

  Teo, Peter Man Lung ^a   Leung, Sing Fai ^a   Chan, Anthony Tak Cheung ^a   Leung, Thomas Wai Tong ^a   Choi, Peter Ho Keung ^a   Kwan, Wing Hong ^a   Lee, Wai Yee ^a   Chau, Ricky Ming Chun ^a   Yu, Peter Kau Wing ^a   Johnson, Philip James ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Hyperfractionation; Nasopharyngeal carcinoma; Neurologic; Radiation toxicities; Randomized study

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN STEM; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRANIAL NERVE; FEMALE; FIBROSIS; HUMAN; HYPOPITUITARISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; METASTASIS; NASOPHARYNX CARCINOMA; NECK INJURY; NEUROLOGICAL COMPLICATION; OPTIC CHIASM; OPTIC NERVE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SOFT TISSUE DISEASE; SPINAL CORD; TEMPORAL LOBE; TRISMUS;

ADOLESCENT; ADULT; AGED; BRAIN DISEASES; CONFIDENCE INTERVALS; CRANIAL NERVE DISEASES; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; RADIATION INJURIES; RELATIVE BIOLOGICAL EFFECTIVENESS; SURVIVAL ANALYSIS; TEMPORAL LOBE; TREATMENT FAILURE;

EID: 0034564112     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00786-0     Document Type: Article

References (50)

1. Nasopharyngeal carcinoma; Local control by megavoltage irradiation
2. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985; Overall survival and patterns of failure
3. Prognostic factors of nasopharyngeal carcinoma; A review of 759 patients
4. A clinical study of 407 cases of nasopharyngeal carcinoma in Hong Kong
5. Nasopharyngeal cancer
6. Patterns of early treatment failure in non-metastatic nasopharyngeal carcinoma; A study based on CT scanning
7. Transpalatal insertion of radioactive gold grain for the treatment of persistent and recurrent nasopharyngeal carcinoma
8. Retrospective analysis of nasopharyngeal carcinoma treated during 1976-1985; Late complications following megavoltage irradiation
9. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985; Survival after local recurrence
10. New approach to the nasopharynx; The maxillary swing approach
11. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx
12. ASTRO plenary. Interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts; Results from Radiation Therapy Oncology Group Protocol 8313
13. Twice a day versus once a day radiation therapy in head and neck cancer
14. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma; Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy
15. Concomitant boost radiotherapy for advanced squamous cell carcinoma of the head and neck
16. Hyperfractionation for head and neck cancer
17. Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts
18. Accelerated fractionation in the radiation treatment of head and neck cancer; A critical comparison of different strategies
19. Radiotherapy employing three fractions on each of twelve consecutive days
20. Local control of oropharyngeal carcinoma after two accelerated hyperfractionation on radiation therapy schemes
21. Status of the experience of the EORTC co-operative group of radiotherapy with hyperfractionated and accelerated radiotherapy regimes
22. The second Klaas Breur Memorial Lecture; LaRonde-Radiation sciences and medical radiology
23. A review of apha/beta ratios for experimental tumours; Implications for clinical studies of altered fractionation
24. Accelerated hyperfractionation radiation therapy for carcinoma of the nasopharynx. Technique and results
25. Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography
26. Asymptomatic temporal lobe injury after radiotherapy for nasopharyngeal carcinoma; Incidence and determinants
27. Early tumour response and treatment toxicity after hyperfractionated radiotherapy in nasopharyngeal carcinoma
28. Stage classification of nasopharyngeal carcinoma
29. Prognostic factors of carcinoma of the nasopharynx
30. Nasopharyngeal cancer; A review of 1605 patients treated radically with cobalt 60
31. Asymptomatic tmporal lobe injury after radiotherapy for nasopharyngeal carcinoma; Incidence and determinants
32. A proposed modification of the Ho stage-classification for nasopharyngeal carcinoma
33. Computed tomography of the nasopharynx and related spaces
34. Radiotherapy for nasopharyngeal carcinoma; Shielding the pituitary may improve therapeutic ratio
35. The linear-quadratic formula and progress in fractionated radiotherapy
36. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses
37. Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality; (Preliminary report) by the Radiation Therapy Oncology Group (RTOG)
38. The hazard of accelerated tumour clonogen repopulation during radiotherapy
39. Caution on the use of altered fractionation for nasopharyngeal carcinoma
40. Experience with CHART
41. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer
42. Altered fractionation in radiotherapy for head and neck cancer; Too early to close the race and announce the winner?
43. Conventional radiotherapy as the primary treatment of squamous cell carcinoma of the head and neck. A randomized multi-center study of 5 versus 6 fractions per week-Preliminary report from DAHANCA 7 trial
44. VUMCA I Trial. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs radiotherapy alone in Stage IV (≥N2, M0) undifferentiated nasopharyngeal carcinoma; A positive effect on progression-free survival
45. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer; Phase III Randomized Intergroup Study 0099
46. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy